MIMI IDICULA: Open Payments
NPI 1003009580 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,407 in 99 payments from 13 companies in 2025. Trend: 2023 $489 · 2024 $1,248 · 2025 $1,407
Food & beverage: $1,407
| Company | Payments | Amount |
|---|---|---|
| Nalu Medical, Inc. | 32 | $360 |
| ABBVIE INC. | 16 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $162 |
| PFIZER INC. | 12 | $158 |
| Collegium Pharmaceutical, Inc. | 12 | $150 |
| Bioventus LLC | 4 | $100 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| SCILEX PHARMACEUTICALS INC. | 4 | $70 |
| Tonix Medicines, Inc. | 3 | $60 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
Products named: Nalu Neurostimulation System, RELISTOR, NURTEC ODT, XTAMPZA, UBRELVY, DUROLANE, Symbravo, TONMYA.
Industry payments across TX — which companies pay providers there.
